CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA

Clinical trials for CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Supercharged immune cells take aim at tough lymphomas in groundbreaking trial

Disease control Ongoing

This study is testing a new type of personalized cell therapy for adults whose CD30+ lymphomas have come back or not responded to standard treatments. Doctors take a patient's own immune cells (T cells), genetically modify them to better find and attack cancer cells, and then inf…

Matched conditions: CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA

Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA

Get alerted when new CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA trials appear

Supercharged immune cells take aim at tough lymphomas in groundbreaking trial